Drug Profile
CD95 ligand
Alternative Names: Fas/APO-1 ligandLatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator University of Tubingen
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 05 Mar 1999 Preclinical development for Cancer in Germany (Unknown route)